The World Health Organisation (WHO) has presented the Malaria Vaccine Implementation program (MVIP) equipment valued at GHc1,130,000, 00 to the Ghana Health Service (GHS).
The items which comprise of two vehicles, 39 motorcycles and 39 desktop computers is to support the MVIP.
Presenting the items, the Country Representative of WHO, Dr. Owen Kaluwa, said the donation is to support the implementation of the project in the 39 districts involved and to facilitate data compilation and analysis; supervision and follow up.
The Director-General of GHS, Dr. Anthony Nsiah-Asare said the items will help ensure that Malaria is eradicated from Ghana.
RTS,S/AS01 is the world’s first malaria vaccine that has been shown to provide partial protection against malaria in young children in large-scale clinical testing.
The vaccine acts against Plasmodium falciparum, the most deadly malaria parasite globally.
The malaria vaccine is being introduced in selected areas of Ghana, Kenya and Malawi through country-led routine immunization, with technical advice from WHO.
Persons adversely affected by malaria vaccine to be compensated – GHS
Meanwhile, Ghana Health Service (GHS) had said that measures have been put in place to compensate persons who may be affected adversely after receiving the malaria vaccine.
According to the GHS, a committee has been set up to look into cases of negative health implications to users of the vaccine.
Dr. Anthony Nsiah-Asare said the vaccine has been certified by the Food and Drugs Authority, and it’s therefore, safe for use.
He said the “Adverse Event Following Immunization (AEFI) committee” monitors closely the vaccination process and “looks at the causal effect and makes sure that we compensate and manage them when they have any problems.”
Credit: Source link